Sign In
Buy PTC
$139.72
-2.62 (-1.84%)
At Close: Jun 03, 2026
Argo Wealth Advisory LLC Invests $2.48 Million in PTC Inc. $PTC
03:27am, Friday, 17'th Apr 2026
Argo Wealth Advisory LLC bought a new position in shares of PTC Inc. (NASDAQ: PTC) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The f
PTC to Announce Fiscal Q2'26 Results on Wednesday, May 6, 2026
07:00am, Monday, 13'th Apr 2026
BOSTON, April 13, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) will release its fiscal 2026 second quarter results and on Wednesday, May 6th after the stock market closes. Senior management will host a liv
CCLA Investment Management Has $117.44 Million Holdings in PTC Inc. $PTC
04:57am, Thursday, 09'th Apr 2026
CCLA Investment Management trimmed its position in PTC Inc. (NASDAQ: PTC) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The f
SG Americas Securities LLC Sells 35,215 Shares of PTC Inc. $PTC
05:01am, Saturday, 04'th Apr 2026
SG Americas Securities LLC lessened its stake in PTC Inc. (NASDAQ: PTC) by 69.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,7
PTC's Codebeamer Gains Traction on BMW Group Digital Push
09:30am, Thursday, 02'nd Apr 2026
PTC's Codebeamer becomes BMW's core engineering platform, unifying data and advancing AI-driven workflows as the company accelerates its intelligent lifecycle vision.
PTC's Codebeamer Adopted by BMW Group to Standardize Requirements Management and Advance Digital Engineering
08:30am, Wednesday, 01'st Apr 2026
Codebeamer becomes standard for requirements management at BMW Group Provides a unified foundation for integrated product development BOSTON, April 1, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today ann
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
08:30am, Wednesday, 25'th Mar 2026
WARREN, N.J., March 25, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced the appointment of Jessica Chutter to its Board of Directors.
Contravisory Investment Management Inc. Makes New Investment in PTC Inc. $PTC
01:42pm, Tuesday, 24'th Mar 2026
Contravisory Investment Management Inc. purchased a new stake in shares of PTC Inc. (NASDAQ: PTC) during the undefined quarter, according to its most recent filing with the Securities and Exchange Com
PTC Completes Kepware & ThingWorx Sale, Raises FY2026 Free Cash Flow View and Details Buybacks
02:02am, Monday, 23'rd Mar 2026
PTC (NASDAQ: PTC) used an investor update call to discuss the completed divestiture of its Kepware and ThingWorx businesses and to outline how the transaction affects fiscal 2026 guidance, cash flow e
PTC Teams with NVIDIA to Unite Design and Robotics Simulation by Connecting Onshape to NVIDIA Isaac Sim
08:30am, Tuesday, 17'th Mar 2026
PTC connects Onshape CAD directly to NVIDIA Isaac Sim in a cloud-native workflow Helps robotics teams move from design to realistic simulation in minutes, while maintaining a single source of truth De
PTC Inc. (PTC) Discusses Divestiture of Kepware and ThingWorx and Provides Updated Financial Guidance Transcript
06:32pm, Monday, 16'th Mar 2026
PTC Inc. (PTC) Discusses Divestiture of Kepware and ThingWorx and Provides Updated Financial Guidance Transcript
PTC COMPLETES DIVESTITURE OF KEPWARE AND THINGWORX BUSINESSES
08:30am, Monday, 16'th Mar 2026
Divestiture of Kepware Industrial Connectivity and ThingWorx IoT businesses enables PTC to increase focus on Intelligent Product Lifecycle vision Updating post-divestiture financial guidance for FY'26
Aquatic Capital Management LLC Makes New $9.21 Million Investment in PTC Inc. $PTC
03:28am, Monday, 16'th Mar 2026
Aquatic Capital Management LLC bought a new stake in PTC Inc. (NASDAQ: PTC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commissio
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 13'th Mar 2026
WARREN, N.J., March 13, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 10, 2026, the company approved non-statutory stock options to purchase an aggregate of
Nvidia's Jensen Huang Thinks the Software Sell-Off Is Wrong: 1 Great Stock to Buy on a Dip
04:05pm, Monday, 09'th Mar 2026
PTC is now embedding AI into its solutions, promising greater efficacy. The company continues to grow its recurring revenue at an impressive rate, and its valuation is at a multiyear low.
